Clinical Trial Update: EFficacy and Impact on Function of Two Different Doses of Nab-paclitaxEl in Elderly With advanCed breasT Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update comparing two nab-paclitaxel doses in elderly patients with advanced breast cancer; results on efficacy and functional impact.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Nab-paclitaxel (paclitaxel protein-bound)

Snippet

Sponsor: Fondazione Sandro Pitigliani | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED